Professional Documents
Culture Documents
Biochemistry - C9 Enzymes Regulation of Activities
Biochemistry - C9 Enzymes Regulation of Activities
Biochemistry - C9 Enzymes Regulation of Activities
BIOMEDICAL IMPORTANCE
CONTROL OF ENZYME SYNTHESIS
Claude Bernard – conceptual basis for
Inducers – promotes synthesis of certain
metabolic regulation
enzymes; substrates that stimulate the
Walter Cannon – coined the term
transcription of the gene that encodes them
“Homeostasis”
An excess of a metabolite may curtail synthesis
Vibrio cholera – causes Cholera; disables
of its cognate enzyme via Repression
sensor response pathways in intestinal epithelial
Both induction and repression involve cis
cells by ADP-ribosylating the GTP-binding
elements, specific DNA sequences and trans-
proteins that link cell surface receptors to
acting regulatory proteins
adenylyl cyclase
Transcription factors – synthesize other
Yersinia pestis – causes Plague; elaborates a
enzymes; is controlled by the interaction of
protein-tyrosine phosphatase that hydrolyzes
hormones and other extracellular signals with
phosphoryl groups on key cytoskeletal proteins
specific cell-surface receptors
Epigenetic – DNA-independent information
systems
CONTROL OF ENZYME DEGRADATION
Aaron Ciechanover
REGULATION OF METABOLITE FLOW
Avram Hershko
Responses to Substrate changes is through
Irwin Rose – earned a Nobel prize for the
Passive means
Ubiquitin-proteasome Pathway
Regulate Enzyme efficiency is in an Active
26S Proteasome where degradation takes
means
place; a large macromolecular subunits
Metabolite flow tends to be Unidirectional; so
arranged in a form of a hollow cylinder
as many reversible reactions occur this way
Proteins are targeted to the interior of the
proteasome by Ubiquination – covalent
COMPARTMENTATION
attachment of one or more ubiquitin molecules
Ensures metabolic efficiency and simplifies
Ubiquitin – 8.5 kDa protein that is highly
regulation
conserved among eukaryotes
Rate Limiting Reaction – decreasing the
Ubiquination – catalyzed by a large family of
catalytic efficiency or the quantity of the
enzymes called E3 ligases, which attach
catalyst responsible for the “bottleneck;”
ubiquitin to the side-chain amino group lysyl
reduces metabolic flux through the entire
residues
pathway
Conversely increasing in quantity or catalytic
UBIQUITIN-PROTEASOME PATHWAY
efficiency will enhance flux through the pathway
Responsible for the regulated degradation of
Acetyl-CoA Carboxylase – catalyzes the
selected cellular proteins and for removal of
synthesis of malonyl-CoA, the 1st committed
defective or aberrant proteins
reaction of fatty acid biosynthesis
Key to the versatility and selectivity resides in
Statin Drugs – synthesis of cholesterol by
the variety of intracellular E3 ligases and their
inhibiting HMG-CoA reductase, catalyst of the
ability to discriminate between the different
rate-limiting reaction of Cholesterogenesis
physical and conformational states of target
proteins
REGULATION OF ENZYME QUANTITY
Catalytic capacity can be controlled by
REGULATION OF CATALYTIC ACTIVITY
changing the quantity of enzymes present;
Allosteric Regulation – changes in intrinsic
altering its intrinsic catalytic efficiency or
catalytic efficiency effected by binding of
combination of both
dissociable ligands
Schoenheimer – Proteins exist in a state of
Covalent Modification- also involved in
“Dynamic Equilibrium” in the body where they
changes
ALLOSTERIC EFFECTORS - Includes Insulin, pepsin, trypsin,
Negative Allosteric Effector – its ability to bind chymotrypsin, several blood clotting factors
and inhibit an enzyme an collagen
Allosteric Site – where a Negative Allosteric Proenzymes/Zymogens – enzymes formed by
effector binds; proposed by Jacques Monod proproteins
Cooperative Feedback Inhibition – where the Proteolytic activation of proproteins constitutes a
effect of an excess of two or more end products physiologically irreversible modification
may be strictly additive, greater than their because reunification of the 2 portions of a
individual effect protein produced by hydrolysis of a peptide bond
Effectors are not isosteric since they are not is entropically disfavored
structurally the same with substrates but rather Proteases as catalytically inactive proenzyme;
Allosteric protect tissue of origin from autodigestion,
Allosteric enzymes – catalysis at the active site such as can occur in pancreatitis
may be modulated by the presence of effectors
at an allosteric site REVERSIBLE COVALENT MODIFICATION
Phosphorylation-Dephosphorylation &
ASPARTATE TRANSCARBAMOYLASE – catalyst for Acetylation-Deacetylation – most common
1st reaction to pyrimidine biosynthesis among the covalent modification
Target of feedback regulation by 2 nucleotide Protein kinase- phosphorylate proteins by
triphosphates, cytidine triphosphate and ADP catalyzing transfer of the terminal phosphoryl
CTP inhibits ATCase, whereas ATP activates it group of ATP
High levels of ATP overcome inhibition of CTP Protein Phosphatase – unmodified form of the
enabling synthesis of pyrimidine to proceed protein can be regenerate by hydrolytic removal
when purine levels are elevated of phosphoryl groups